Health & Fitness
Health and Fitness
Health and Fitness
Mon, July 19, 2010
Sun, July 18, 2010
Sat, July 17, 2010
Fri, July 16, 2010
Thu, July 15, 2010 Cytori Therapeutics, Embraer, Intel, NVIDIA and Advanced Micro Devices
CHICAGO--([ BUSINESS WIRE ])--[ Zacks Equity Research ] highlights: Cytori Therapeutics (Nasdaq: [ CYTX ]) as the Bull of the Day and Embraer (NYSE: [ ERJ ]) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Intel Corp. (Nasdaq: [ INTC ]), NVIDIA Corp (Nasdaq: [ NVDA ]) and Advanced Micro Devices (NYSE: [ AMD ]).
Full analysis of all these stocks is available at [ http://at.zacks.com/?id=2678 ].
Here is a synopsis of all five stocks:
[ Bull of the Day ]:
We continue to be very positive on Cytori Therapeutics (Nasdaq: [ CYTX ]) and believe the company's Celution System, a better mousetrap for quickly and efficiently harvesting adult stem cells, will see sales ramp significantly over the next few years.
Sales of the system have been tracking with our expectations. Ultimately, the clinical data will determine the pace at which the ramp continues. So far, the clinical data has been exciting, and with several investigator-sponsored programs ongoing.
Additional data expected over the next few years will have an immediate impact on the financial results. Today's price represents an attractive entry point. We are maintaining our Outperform rating and $10 target.
[ Bear of the Day ]:
The international economic environment remains an issue for aircraft manufacturer Empresa Brasileira de Aeronautica S.A., or Embraer (NYSE: [ ERJ ]), considering the company's exposure to the U.S. and European markets.
Moreover, the company's high dependence on some models, with a primary focus on American airline companies, exposes it to considerable risks. The considerable strain on the Brazilian airport infrastructure will also impact the company's local top line results.
We do not expect better prospects for the industry. Thus, we have reduced our earnings estimate for fiscal 2010 from $1.39 to $1.31 per ADR and downgraded our recommendation on the ADR from Neutral to Underperform.
Latest Posts on the Zacks [ Analyst Blog ]:
Intel Signals Strong Year for Semis
Intel Corp (Nasdaq: [ INTC ]) reported another stellar quarter, beating the Zacks Consensus Estimate by 8 cents. The earnings beat was the result of record revenue, gross margin, operating profit and EPS in the last quarter. Shares climbed 7.04% after hours in response to the news.
We come away with a few observations.
First, cloud computing and transfer of data to the Internet are impacting Intela™s results sooner than we expected. Second, the enterprise refresh cycle is also happening sooner than expected. Third, there appears to be no letup in demand for consumer computing gadgets. Fourth, concerns regarding Europe are not unduly impacting results, with Intel on-track to easily beat its PC market growth estimate of around 20% for the year.
We are also compelled to comment on managementa™s excellent execution, which keeps the company on track to deliver 32nm products ahead of the rest of the industry. This, along with strong demand for newer, higher-margin products are driving earnings growth for Intel.
Despite all these positives, we believe the shares will remain under pressure due to the situation in Europe, Intela™s much publicized legal troubles with graphics partner NVIDIA Corp (Nasdaq: [ NVDA ]) and increasing competition from a resurgent Advanced Micro Devices (NYSE: [ AMD ]). We have therefore allotted a Zacks rank of #3 to Intel shares.
Get the full analysis of all these stocks by going to [ http://at.zacks.com/?id=2649 ].
About the Bull and Bear of the Day
Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.
About the Analyst Blog
Updated throughout every trading day, the [ Analyst Blog ] provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks [ "Profit from the Pros" ] e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting [ http://at.zacks.com/?id=7158 ].
About Zacks
Zacks.com is a property of [ Zacks Investment Research ], Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the [ Zacks Rank ], which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at [ http://at.zacks.com/?id=4582 ].
Visit [ http://www.zacks.com/performance ] for information about the performance numbers displayed in this press release.
Follow us on Twitter: [ http://twitter.com/zacksresearch ].
Join us on Facebook: [ http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts ].
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
